EBMT activity survey 2004 and changes in disease indication over the past 15 years
The modification of high-dose therapy shortens the duration of neutropaenia by delay of leucocyte nadir
Autologous stem cell transplantation in patients with chronic lymphocytic leukaemia: the Finnish experience
Prolonged responses after autologous stem cell transplantation in African-American patients with multiple myeloma
Skin cancer after nonmyeloablative hematopoietic cell transplantation
Endocrine dysfunction and parameters of the metabolic syndrome after bone marrow transplantation during childhood and adolescence
Rapid helper T-cell recovery above 200 × 106/l at 3 months correlates to successful transplant outcomes after allogeneic stem cell transplantation
Long-term follow-up of myeloablative allogeneic stem cell transplantation using Campath 'in the bag' as T-cell depletion: the Leiden experience
Prognostic factors for donor lymphocyte infusions following non-myeloablative allogeneic stem cell transplantation in multiple myeloma
Combination antithymocyte globulin and soluble TNFα inhibitor (etanercept) +/− mycophenolate mofetil for treatment of steroid refractory acute graft-versus-host disease
Response to high-dose dexamethasone for acquired pure red cell aplasia following ABO-mismatched allogeneic stem cell transplantation